Drug interactions
Insulin aspart-insulin aspart protamine + Rosiglitazone
Severity: Major
Insulin aspart-insulin aspart protamine and Rosiglitazone: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Rosiglitazone with insulin increases the risk of hypoglycemia, fluid retention, edema and heart failure. The combination is generally discouraged because of cardiovascular concerns.
What this interaction means in plain words
Insulin aspart-insulin aspart protamine and Rosiglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Insulin aspart-insulin aspart protamine belongs to Endocrine; Rosiglitazone belongs to Endocrine.
Why it happens
Additive glucose lowering through PPAR-gamma insulin sensitization with insulin; both contribute to fluid retention.
What to do
Avoid in patients with heart failure or high cardiac risk. If used, monitor for fluid retention and glucose and reduce insulin as needed.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Insulin aspart-insulin aspart protamine and Rosiglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Insulin aspart-insulin aspart protamine
- Ethanol + Insulin aspart-insulin aspart protamine Major
- Insulin aspart-insulin aspart protamine + Pentamidine Major
- Insulin aspart-insulin aspart protamine + Pioglitazone Major
- Acarbose + Insulin aspart-insulin aspart protamine Moderate
- Albiglutide + Insulin aspart-insulin aspart protamine Moderate
- Alogliptin + Insulin aspart-insulin aspart protamine Moderate
Other interactions of Rosiglitazone
Frequently asked questions
Can I take Insulin aspart-insulin aspart protamine with Rosiglitazone?
MediHelp rates the interaction as major. Insulin aspart-insulin aspart protamine and Rosiglitazone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Rosiglitazone with insulin increases the risk of hypoglycemia, fluid retention, edema and heart failure. The combination is generally discouraged because of cardiovascular concerns.
How serious is the interaction between Insulin aspart-insulin aspart protamine and Rosiglitazone?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid in patients with heart failure or high cardiac risk. If used, monitor for fluid retention and glucose and reduce insulin as needed.
What other medicines interact with Insulin aspart-insulin aspart protamine?
MediHelp also lists interactions of Insulin aspart-insulin aspart protamine with, for example, Ethanol, Pentamidine, Pioglitazone. The full list is on the Insulin aspart-insulin aspart protamine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
